Zelira in the news
Articles
For media related enquiries please contact Damien Carbon at Profile Media
Ph: +61 (0) 412 332 122 E: damienc@profilemedia.com.au
09 Dec 2015 – Q&A Proactive Investors
Gleneagle Gold (ASX:GLN) has positioned itself to transition into the medical cannabis sector after entering into an agreement in relation to acquiring 100% of the issued capital of Zelda Therapeutics Pty Ltd.